Delphia (USA)’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-518
Closed -$61K 402
2021
Q4
$61K Buy
+518
New +$61K 0.06% 263